Aberrantly methylated PKP1 in the progression of Barrett's esophagus to esophageal adenocarcinoma

Genes Chromosomes and Cancer

Volumn 51, Issue 4, 2012, Pages 384-393

  Kaz, Andrew M ^a,b,c   Luo, Yanxin ^a,d,e   Dzieciatkowski, Slavomir ^a   Chak, Amitabh ^f   Willis, Joseph E ^f   Upton, Melissa P ^b   Leidner, Rom S ^f   Grady, William M ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d The Second Affiliated Hospital   (China)

^e SUN YAT SEN UNIVERSITY   (China)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLAKOPHILIN 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BARRETT ESOPHAGUS; CELL MOTILITY; CONTROLLED STUDY; DESMOSOME; DISEASE COURSE; DNA METHYLATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CELL MOVEMENT; DESMOSOMES; DISEASE PROGRESSION; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; HUMANS; PLAKOPHILINS; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84856784723     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.21923     Document Type: Article

References (40)

1. Bailey T, Biddlestone L, Shepherd N, Barr H, Warner P, Jankowski J. 1998. Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: Correlation with disease progression and dedifferentiation. Am J Pathol 152: 135-144.
2. Bass-Zubek AE, Godsel LM, Delmar M, Green KJ. 2009. Plakophilins: Multifunctional scaffolds for adhesion and signaling. Curr Opin Cell Biol 21: 708-716.
3. Blot WJ, McLaughlin JK. 1999. The changing epidemiology of esophageal cancer. Semin Oncol 26 ( 5 Suppl 15 ): 2-8.
4. Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T. 2005. BiQ Analyzer: Visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics 21: 4067-4068.
5. Breuninger S, Reidenbach S, Sauer CG, Strobel P, Pfitzenmaier J, Trojan L, Hofmann I. 2010. Desmosomal plakophilins in the prostate and prostatic adenocarcinomas: Implications for diagnosis and tumor progression. Am J Pathol 176: 2509-2519.
6. Cheng X, Den Z, Koch PJ. 2005. Desmosomal cell adhesion in mammalian development. Eur J Cell Biol 84: 215-223.
7. Clement G, Braunschweig R, Pasquier N, Bosman FT, Benhattar J. 2006. Methylation of APC, TIMP3, and TERT: A new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation. J Pathol 208: 100-107.
8. de Moor CH, Meijer H, Lissenden S. 2005. Mechanisms of translational control by the 3' UTR in development and differentiation. Semin Cell Dev Biol 16: 49-58.
9. Depondt J, Shabana AH, Florescu-Zorila S, Gehanno P, Forest N. 1999. Down-regulation of desmosomal molecules in oral and pharyngeal squamous cell carcinomas as a marker for tumour growth and distant metastasis. Eur J Oral Sci 107: 183-193.
10. Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, Peters JH, DeMeester SR, DeMeester TR, Skinner KA, Laird PW. 2001. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 61: 3410-3418.
11. Flejou JF. 2005. Barrett's oesophagus: From metaplasia to dysplasia and cancer. Gut 54: i6-i12.
12. Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG, Kim SJ, Markowitz S. 2000. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 26: 16-17.
13. Hamilton JP, Sato F, Greenwald BD, Suntharalingam M, Krasna MJ, Edelman MJ, Doyle A, Berki AT, Abraham JM, Mori Y, Kan T, Mantzur C, Paun B, Wang S, Ito T, Jin Z, Meltzer SJ. 2006. Promoter methylation and response to chemotherapy and radiation in esophageal cancer. Clin Gastroenterol Hepatol 4: 701-708.
14. Hatzfeld M. 2007. Plakophilins: Multifunctional proteins or just regulators of desmosomal adhesion? Biochim Biophys Acta 1773: 69-77.
15. Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, Van Den Berg D, Malik S, Pan F, Noushmehr H, van Dijk CM, Tollenaar RA, Laird PW. 2011. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 2011 Jun. 9 [Epub].
16. Hinshelwood RA, Melki JR, Huschtscha LI, Paul C, Song JZ, Stirzaker C, Reddel RR, Clark SJ. 2009. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Hum Mol Genet 18: 3098-3109.
17. Jackson RJ, Hellen CU, Pestova TV. 2010. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 11: 113-127.
18. Jawhari AU, Noda M, Pignatelli M, Farthing M. 1999. Up-regulated cytoplasmic expression, with reduced membranous distribution, of the src substrate p120(ctn) in gastric carcinoma. J Pathol 189: 180-185.
19. Jin Z, Cheng Y, Gu W, Zheng Y, Sato F, Mori Y, Olaru AV, Paun BC, Yang J, Kan T, Ito T, Hamilton JP, Selaru FM, Agarwal R, David S, Abraham JM, Wolfsen HC, Wallace MB, Shaheen NJ, Washington K, Wang J, Canto MI, Bhattacharyya A, Nelson MA, Wagner PD, Romero Y, Wang KK, Feng Z, Sampliner RE, Meltzer SJ. 2009. A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. Cancer Res 69: 4112-4115.
20. Jovov B, Van Itallie CM, Shaheen NJ, Carson JL, Gambling TM, Anderson JM, Orlando RC. 2007. Claudin-18: A dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance. Am J Physiol Gastrointest Liver Physiol 293: G1106-G1113.
21. Kaz A, Kim YH, Dzieciatkowski S, Lynch H, Watson P, Kay Washington M, Lin L, Grady WM. 2007. Evidence for the role of aberrant DNA methylation in the pathogenesis of Lynch syndrome adenomas. Int J Cancer 120: 1922-1929.
22. Kottke MD, Delva E, Kowalczyk AP. 2006. The desmosome: Cell science lessons from human diseases. J Cell Sci 119: 797-806.
23. Kurzen H, Munzing I, Hartschuh W. 2003. Expression of desmosomal proteins in squamous cell carcinomas of the skin. J Cutan Pathol 30: 621-630.
24. Lind GE, Thorstensen L, Lovig T, Meling GI, Hamelin R, Rognum TO, Esteller M, Lothe RA. 2004. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer 3: 28.
25. Maley CC, Galipeau PC, Finley JC, Wongsurawat VJ, Li X, Sanchez CA, Paulson TG, Blount PL, Risques RA, Rabinovitch PS, Reid BJ. 2006. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet 38: 468-473.
26. Meyer S, Temme C, Wahle E. 2004. Messenger RNA turnover in eukaryotes: Pathways and enzymes. Crit Rev Biochem Mol Biol 39: 197-216.
27. Moll I, Kurzen H, Langbein L, Franke WW. 1997. The distribution of the desmosomal protein, plakophilin 1, in human skin and skin tumors. J Invest Dermatol 108: 139-146.
28. Neuber S, Muhmer M, Wratten D, Koch PJ, Moll R, Schmidt A. 2010. The desmosomal plaque proteins of the plakophilin family. Dermatol Res Pract 2010: 101452.
29. Papagerakis S, Shabana AH, Depondt J, Gehanno P, Forest N. 2003. Immunohistochemical localization of plakophilins (PKP1, PKP2, PKP3, and p0071) in primary oropharyngeal tumors: Correlation with clinical parameters. Hum Pathol 34: 565-572.
30. Peng D, Hu TL, Jiang A, Washington MK, Moskaluk CA, Schneider-Stock R, El-Rifai W. 2011. Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas. PLoS One 6: e22009.
31. Petko Z, Ghiassi M, Shuber A, Gorham J, Smalley W, Washington MK, Schultenover S, Gautam S, Markowitz SD, Grady WM. 2005. Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res 11: 1203-1209.
32. Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. 2000. Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 95: 1669-1676.
33. Schmitt-Graeff A, Koeninger A, Olschewski M, Haxelmans S, Nitschke R, Bochaton-Piallat ML, Lifschitz-Mercer B, Gabbiani G, Langbein L, Czernobilsky B. 2007. The Ki67+ proliferation index correlates with increased cellular retinol-binding protein-1 and the coordinated loss of plakophilin-1 and desmoplakin during progression of cervical squamous lesions. Histopathology 51: 87-97.
34. Shibata T, Kokubu A, Sekine S, Kanai Y, Hirohashi S. 2004. Cytoplasmic p120ctn regulates the invasive phenotypes of E-cadherin-deficient breast cancer. Am J Pathol 164: 2269-2278.
35. Sobolik-Delmaire T, Katafiasz D, Keim SA, Mahoney MG, Wahl JK, III. 2007. Decreased plakophilin-1 expression promotes increased motility in head and neck squamous cell carcinoma cells. Cell Commun Adhes 14: 99-109.
36. South AP, Wan H, Stone MG, Dopping-Hepenstal PJ, Purkis PE, Marshall JF, Leigh IM, Eady RA, Hart IR, McGrath JA. 2003. Lack of plakophilin 1 increases keratinocyte migration and reduces desmosome stability. J Cell Sci 116: 3303-3314.
37. Spechler SJ. 2002. Clinical practice. Barrett's Esophagus. N Engl J Med 346: 836-842.
38. Tischoff I, Hengge UR, Vieth M, Ell C, Stolte M, Weber A, Schmidt WE, Tannapfel A. 2007. Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's adenocarcinoma. Gut 56: 1047-1053.
39. Werner M, Mueller J, Walch A, Hofler H. 1999. The molecular pathology of Barrett's esophagus. Histol Histopathol 14: 553-559.
40. Wijnhoven BP, Dinjens WN, Pignatelli M. 2000. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 87: 992-1005.